Ayurcann Holdings Sees Double-Digit Revenue Growth In 2025, Expands National Retail Presence

Canadian cannabis company Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) reported CA$55.4 million ($34.7 million) in gross revenue for the fiscal year ended June 30, 2025, compared to CA$45.3 million in 2024.

Adjusted EBITDA came in positive at CA$507,570, while the product portfolio expanded to 80 SKUs nationwide, the company said on Tuesday.

“As the cannabis industry continues to mature in Canada, we are thrilled to see sustained growth and strong demand for our brands across multiple provinces,” Igal Sudman, Ayurcann’s CEO, said. “Despite price compression and competitive pressures, our focus on the business-to-consumer market has enabled Ayurcann to expand market share, diversify product offerings, and strengthen brand loyalty nationwide.”

The company said its products are now available in more than 75% of licensed retail cannabis stores nationwide.

Additionally, it features over 35,500 product listings in dispensaries across Ontario, New Brunswick, Manitoba, Saskatchewan, Alberta, British Columbia, Newfoundland, and Yukon.

Simultaneously, Ayurcann said it will voluntarily delist from the OTC Markets Group OTCQB Venture Market, effective October 30, 2025.

The company’s shares will continue to trade in Canada on the Canadian Securities Exchange under the current ticker symbol “AYUR”.